Efficacy News and Research

RSS

COVID-19 vaccine clinical trial for children is underway in St. Louis

A pediatric COVID-19 vaccine clinical trial is underway in St. Louis. Led by Washington University School of Medicine, about 140 area children will receive the two-shot Moderna vaccine or placebo at St. Louis Children's Hospital as part of a clinical trial involving about 100 medical institutions in the U.S. and Canada.

6 Oct 2021

HPV vaccine hesitancy has now stabilized or increased in some ethnic and age groups

A study that tracked parental opinion about the human papillomavirus (HPV) vaccine showed that after hesitancy decreased for several years, hesitancy has now either stabilized or increased in some ethnic and age groups, according to results presented at the virtual 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held October 6-8, 2021.

6 Oct 2021

Does vaccination prevent long COVID?

In a recent study, researchers evaluate the effect of COVID-19 vaccination on a large ongoing prospective cohort of patients with long COVID.

6 Oct 2021

Moderna COVID vaccine booster dose results in immune memory

A recent study presents evidence that a booster dose of the Moderna vaccine can induce a robust memory immune response against COVID-19.

6 Oct 2021

Research on twins indicates strong genetic influences in COVID-19

A new study discusses the strong possibility of multifactorial causation for SARS-CoV-2 infection using data from twin studies.

6 Oct 2021

KU Leuven researchers develop an ultrapotent inhibitor of dengue virus

Researchers at the KU Leuven Rega Institute and CD3 have developed an ultrapotent inhibitor of the dengue virus, which causes the tropical disease known as dengue.

6 Oct 2021

Researchers capture mechanisms for predicting cartilage degradation and recovery after ACL injury

Post-traumatic osteoarthritis is a musculoskeletal disorder shadowing especially the life of young and active population.

6 Oct 2021

First of its kind ‘living medicine’ designed to treat antibiotic-resistant bacteria on medical implants

Researchers at the Centre for Genomic Regulation and Pulmobiotics S.L have created the first 'living medicine' to treat antibiotic-resistant bacteria growing on the surfaces of medical implants. The researchers created the treatment by removing a common bacteria's ability to cause disease and repurposing it to attack harmful microbes instead.

6 Oct 2021

Comparative analysis between the SARS-CoV-1 and SARS-CoV-2 mPro systems

To better understand the biophysical changes that occur due to mutations, the mechanisms of multiple SARS-CoV-2 proteins have been studied and compared with SARS-CoV-1.

6 Oct 2021

Cysteamine inhibits SARS-CoV-2 variants of concern in vitro

Researchers in the United States have shown that a compound currently used to treat cystinosis exhibits broad antiviral activity against variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

5 Oct 2021

New mathematical modeling technique can accurately predict tumor response to chemotherapy

A public/private collaboration led by researchers at The University of Texas at Austin has resulted in a new mathematical modeling technique that can accurately predict the response of tumors in breast cancer patients to treatments such as chemotherapy soon after treatment initiation.

5 Oct 2021

AstraZeneca COVID-19 vaccine safe and effective in phase 3 U.S., Chile, and Peru trial

A new study reports on the results of phase III clinical trial on the safety and efficacy of the AstraZeneca-Oxford COVID-19 vaccine.

5 Oct 2021

Anti-nucleocapsid SARS-Cov-2 antibodies wane over time in long-term care facilities

A new study shows that up to a third of survivors in LTCFs were infected during the first year after infection.

5 Oct 2021

Managing metabolic disease through time-restricted eating

In this interview, News-Medical speaks to Dr. Satchin Panda about his latest research into time-restricted eating and how it can be used to manage metabolic diseases.

5 Oct 2021

Depressed seroconversion in immunocompromised COVID-19 vaccine recipients

Researchers from the University of Singapore have reviewed the data in post-vaccinated immunocompromised patients to examine the effectiveness of these vaccines in these patients.

5 Oct 2021

Saliva test could be used for lithium monitoring among patients with mood disorders

Lithium is a common medication prescribed to patients with psychiatric disorders, namely bipolar disorder, schizophrenia, and depression.

4 Oct 2021

Moderna's COVID-19 vaccine proves effective against multiple SARS-CoV-2 variants, including delta

Researchers in the United States have demonstrated the real-world effectiveness of Moderna’s mRNA-1273 vaccine at protecting against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and preventing hospitalization due to coronavirus disease 2019 (COVID-19).

4 Oct 2021

Efficacy News and Research

COVID-19 vaccine clinical trial for children is underway in St. Louis

HPV vaccine hesitancy has now stabilized or increased in some ethnic and age groups

Does vaccination prevent long COVID?

Moderna COVID vaccine booster dose results in immune memory

Research on twins indicates strong genetic influences in COVID-19

KU Leuven researchers develop an ultrapotent inhibitor of dengue virus

Researchers capture mechanisms for predicting cartilage degradation and recovery after ACL injury

First of its kind ‘living medicine’ designed to treat antibiotic-resistant bacteria on medical implants

Comparative analysis between the SARS-CoV-1 and SARS-CoV-2 mPro systems

Cysteamine inhibits SARS-CoV-2 variants of concern in vitro

New mathematical modeling technique can accurately predict tumor response to chemotherapy

AstraZeneca COVID-19 vaccine safe and effective in phase 3 U.S., Chile, and Peru trial

Anti-nucleocapsid SARS-Cov-2 antibodies wane over time in long-term care facilities

Managing metabolic disease through time-restricted eating

Depressed seroconversion in immunocompromised COVID-19 vaccine recipients

Saliva test could be used for lithium monitoring among patients with mood disorders

Moderna's COVID-19 vaccine proves effective against multiple SARS-CoV-2 variants, including delta

Study looks at immunosuppressants and COVID vaccine efficacy

J&J vaccine prevents SARS-CoV-2-induced thrombosis and inflammation in hamsters

Researchers launch new study of COVID-19 vaccination schedules in 12-to-16-year-olds

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News